Intervention Review

Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization

  1. Joseph T Thomas1,*,
  2. Peter Muller2,
  3. Christopher S Wilkinson2

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 18 APR 2007

Assessed as up-to-date: 23 JUN 2009

DOI: 10.1002/14651858.CD005541.pub2


How to Cite

Thomas JT, Muller P, Wilkinson CS. Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD005541. DOI: 10.1002/14651858.CD005541.pub2.

Author Information

  1. 1

    Mater Health Services, Maternal Fetal Medicine and Obstetrics, South Brisbane, Queensland, Australia

  2. 2

    Women's and Children's Hospital, Department of Perinatal Medicine, Adelaide, Australia

*Joseph T Thomas, Maternal Fetal Medicine and Obstetrics, Mater Health Services, Aubigny Place, Raymond Terrace, South Brisbane, Queensland, 4101, Australia. joseph.thomas@mater.org.au.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 18 APR 2007

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter H. Dijk, Christian V. Hulzebos, An evidence-based view on hyperbilirubinaemia, Acta Paediatrica, 2012, 101,
  2. 2
    S. T. Johnson, G. J. Bell, L. J. McCargar, R. S. Welsh, R. C. Bell, Improved cardiovascular health following a progressive walking and dietary intervention for type 2 diabetes, Diabetes, Obesity and Metabolism, 2009, 11, 9